Obviously, these changes are highly significant for the outcome of any gene therapy focusing on bipolar cells, for instance if mGluR6 is chosen as a promoter ( Cronin et al., 2014 ).
1
—
—
Obviously, these changes are highly significant for the outcome of any gene therapy focusing on bipolar cells, for instance if mGluR6 is chosen as a promoter ( Cronin et al., 2014 ).